Attovia Therapeutics, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Attovia Therapeutics, Inc. (ATTO) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 24.44 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-09-02.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-09-02
- 2026-06-30: Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month 24.44M shares.
- 2025-06-30: Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month 24.62M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month |
|---|---|
| 2026-06-30 | 24.44M shares 10-Q · filed 2026-09-02 |
| 2025-06-30 | 24.62M shares 10-Q · filed 2026-09-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |